Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Series Title
      Series Title
      Clear All
      Series Title
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Content Type
    • Item Type
    • Is Full-Text Available
    • Subject
    • Country Of Publication
    • Publisher
    • Source
    • Target Audience
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
714 result(s) for "O'Connor, George"
Sort by:
Olympians
Retells in graphic novel format stories from Greek mythology about the exploits of the young Zeus; Athena, goddess of wisdom; the heroes who sought and won Hera's patronage; Hades and Persephone; Poseidon, god of the seas; and Aphrodite.
The Health Effects of Electronic Cigarettes
The use of electronic cigarettes is growing, and some hope that they will replace what is felt to be the more dangerous nicotine-delivery system — cigarettes. However, data on the long-term safety of e-cigarettes are still being gathered. Electronic cigarettes (e-cigarettes), also known as electronic nicotine-delivery systems, are devices that produce an aerosol by heating a liquid that contains a solvent (vegetable glycerin, propylene glycol, or a mixture of these), one or more flavorings, and nicotine, although the nicotine may be omitted. The evaporation of the liquid at the heating element is followed by rapid cooling to form an aerosol. This process is fundamentally different from the combustion of tobacco, and consequently the composition of the aerosol from e-cigarettes and the smoke from tobacco is quite different. E-cigarette aerosol is directly inhaled (or “vaped”) by the user through . . .
Athena : grey-eyed goddess
From the moment she emerged, fully grown, from the head of Zeus, Athena was one of the most complex Olympians. This graphic novel retells her many interwoven tales: how she killed Pallas, fought the Gigantes, aided Perseus, and cursed Arachne.
Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction
In a previously published controlled trial, maternal administration of vitamin D during pregnancy was found to protect against wheeze in the offspring at the age of 3 years. In this follow-up study involving the same children at the age of 6 years, that supplementation no longer had a protective effect.
Poseidon : earth shaker
Graphically adapts the adventures of the Greek god of the seas, presenting the myth of how Poseidon became the king of the oceans and such stories as Theseus and the Minotaur, Odysseus and Polyphemos, and the founding of Athens.
E-Cigarettes to Assist with Smoking Cessation
The prevalence of tobacco smoking in the United States has declined to 14.0% but still exceeds 25% among high-risk subgroups. 1,2 Electronic cigarettes (e-cigarettes) are not approved by the Food and Drug Administration (FDA) for smoking cessation, but Americans trying to quit smoking use these products more frequently than FDA-approved cessation aids. 3 Comparative-effectiveness trials are needed to learn whether smokers have a better chance of quitting with e-cigarettes. Previous trials have had methodologic shortcomings, used first-generation e-cigarettes, or did not assess long-term outcomes. Hajek et al. 4 now report in the Journal the results of a multicenter, pragmatic, randomized trial of e-cigarettes, . . .
Long-Term Exposure to Traffic Emissions and Fine Particulate Matter and Lung Function Decline in the Framingham Heart Study
Few studies have examined associations between long-term exposure to fine particulate matter (PM2.5) and lung function decline in adults. To determine if exposure to traffic and PM2.5 is associated with longitudinal changes in lung function in a population-based cohort in the Northeastern United States, where pollution levels are relatively low. FEV1 and FVC were measured up to two times between 1995 and 2011 among 6,339 participants of the Framingham Offspring or Third Generation studies. We tested associations between residential proximity to a major roadway and PM2.5 exposure in 2001 (estimated by a land-use model using satellite measurements of aerosol optical thickness) and lung function. We examined differences in average lung function using mixed-effects models and differences in lung function decline using linear regression models. Current smokers were excluded. Models were adjusted for age, sex, height, weight, pack-years, socioeconomic status indicators, cohort, time, season, and weather. Living less than 100 m from a major roadway was associated with a 23.2 ml (95% confidence interval [CI], -44.4 to -1.9) lower FEV1 and a 5.0 ml/yr (95% CI, -9.0 to -0.9) faster decline in FEV1 compared with more than 400 m. Each 2 μg/m(3) increase in average of PM2.5 was associated with a 13.5 ml (95% CI, -26.6 to -0.3) lower FEV1 and a 2.1 ml/yr (95% CI, -4.1 to -0.2) faster decline in FEV1. There were similar associations with FVC. Associations with FEV1/FVC ratio were weak or absent. Long-term exposure to traffic and PM2.5, at relatively low levels, was associated with lower FEV1 and FVC and an accelerated rate of lung function decline.
If I had a triceratops
A little boy wonders about what it would be like to have a triceratops for a pet and imagines playing fetch, teaching her tricks, and cuddling up with her at the end of the night.
Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study
The relationship between the development and/or progression of interstitial lung abnormalities (ILA) and clinical outcomes has not been previously investigated. To determine the risk factors for, and the clinical consequences of, having ILA progression in participants from the Framingham Heart Study. ILA were assessed in 1,867 participants who had serial chest computed tomography (CT) scans approximately 6 years apart. Mixed effect regression (and Cox) models were used to assess the association between ILA progression and pulmonary function decline (and mortality). During the follow-up period 660 (35%) participants did not have ILA on either CT scan, 37 (2%) had stable to improving ILA, and 118 (6%) had ILA with progression (the remaining participants without ILA were noted to be indeterminate on at least one CT scan). Increasing age and increasing copies of the MUC5B promoter polymorphism were associated with ILA progression. After adjustment for covariates, ILA progression was associated with a greater FVC decline when compared with participants without ILA (20 ml; SE, ±6 ml; P = 0.0005) and with those with ILA without progression (25 ml; SE, ±11 ml; P = 0.03). Over a median follow-up time of approximately 4 years, after adjustment, ILA progression was associated with an increase in the risk of death (hazard ratio, 3.9; 95% confidence interval, 1.3-10.9; P = 0.01) when compared with those without ILA. These findings demonstrate that ILA progression in the Framingham Heart Study is associated with an increased rate of pulmonary function decline and increased risk of death.